Understanding AI's Expanding Role in Drug Dis...

Retiring workers can take operational knowledge with them, while difficult-to-use enterprise systems leave other information underused. In this episode, Vaibhav Kumar, Global Chief Technology Officer at IFS, joins Emerj's Eysan Yazici to examine how conversational AI could help i ...  Show more

GPU clusters sit idle and budgets balloon when storage can't keep pace with how fast AI workloads are scaling. In this episode, Cameron Bahar, GM of Scale AI at Everpure, explores how storage architecture must shift from rigid, single-purpose systems to flexible, cloud-like model ...  Show more

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more

Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion, talks about the next frontier in healthcare: disease modeling. Shai shares how CytoReason bridges the gap between exploding biological data and actionable insight, powering smarter, faster ...  Show more

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ...  Show more